Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-16 · accession 0001735276-25-000071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-19 | 2025-05-16 | ALNY | Greenstreet Yvonne | CEO, Dir | G - Gift | $0.00 | -8,376 | 48.9K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-16 | G | D | 8,376 | $0.00 | 48,948 | D | — | — |